-
Filter By Category
- Cleaning Accessories (1)
- Cloths and Wipes (1)
- Cleaning Chemicals (6)
- Disinfectant (2)
- Floor (4)
-
Filter By Stock
- In Stock (19)
Whiteley Products
RRP $89.95
$87.95
$79.95 Ex GST
RRP $89.95
$79.95
$72.68 Ex GST
RRP $19.95
$16.95
$15.41 Ex GST
RRP $19.95
$16.95
$15.41 Ex GST
RRP $89.95
$79.95
$72.68 Ex GST
RRP $19.95
$16.95
$15.41 Ex GST
RRP $89.95
$79.95
$72.68 Ex GST
RRP $19.95
$16.95
$15.41 Ex GST
RRP $89.95
$79.95
$72.68 Ex GST
RRP $19.95
$16.95
$15.41 Ex GST
RRP $89.95
$79.95
$72.68 Ex GST
RRP $34.95
$31.95
$29.05 Ex GST
RRP $59.95
$49.95
$45.41 Ex GST
RRP $59.95
$52.95
$48.14 Ex GST
RRP $34.95
$29.95
$27.23 Ex GST
RRP $54.95
$47.95
$43.59 Ex GST
RRP $17.95
$14.95
$13.59 Ex GST
RRP $179.95
$164.95
$149.95 Ex GST
top seller
RRP $15.95
$14.95
$13.59 Ex GST
top seller
RRP $69.95
$59.95
$54.50 Ex GST
RRP $78.95
$70.95
$64.50 Ex GST
Welcome to Whiteley Products:
Pioneering Excellence in Infection Prevention
Whiteley, a TGA licensed manufacturer of therapeutic goods, operates on the campus in Tomago, in the Hunter Region of New South Wales. Renowned for manufacturing innovative products that meet international standards for cleaning and disinfection, Whiteley provides high-quality solutions across various fields, including Endoscopy, Surgical and Theatre, Hospital Infection Prevention, Central Sterilisation Departments, Aged Care, Contract Cleaning, and Professional Cleaning Services.
A family-owned Australian business, Whiteley is led by Dr. Greg Whiteley, a globally recognized expert in Infection Prevention and Control. Operating throughout the Asia Pacific and exporting to over 20 international markets, including Southeast Asia, China, and the US, Whiteley has made its mark on the global stage.
Innovation through Clinical Research
Whiteley maintains an obsessive focus on clinical research to drive constant innovation in the vital area of Infection Prevention. Their commitment to research programs in emerging fields, such as bacterial biofilms, has resulted in world-first technologies, including Surfex® – the world's first dry surface biofilm remover. Several publications from Whiteley are recognized as seminal papers in the field, particularly with Dry Surface Biofilms.
Continued Focus on Superbug Research
While the height of the SARS-CoV-2 (COVID-19) pandemic may be behind us, Whiteley recognizes that superbugs will continue to pose a threat. The brand remains dedicated to the development of appropriate hygiene interventions. Whiteley's ongoing research explores how superbugs bind onto surfaces and the transfer mechanisms that lead to infections. Understanding how to prevent these biofilms from forming and contributing to patient infections has the potential to save thousands of lives. The intent is not to replace antibiotics but to provide additional processes and defenses in the prevention or treatment of infections. In recognition of his groundbreaking work, Dr. Greg Whiteley was recently appointed as an Adjunct Associate Professor in the Faculty of Medicine and Health at the University of Sydney.
A Bright Future for Whiteley
From its humble beginnings during the Great Depression to the current global fight against pandemics and superbugs, the future looks bright for Whiteley. With new products, claims, research initiatives, facilities, and numerous product opportunities being explored, Whiteley eagerly anticipates delivering even more leading cleaning and disinfection technology to the market in the future.
Dr. Greg Whiteley adds, "While there is still the ability to protect lives and livelihoods, Whiteley will be continuing to fulfill its company mission of protecting lives and livelihoods."
